The U.S. Food and Drug Administration on Tuesday approved leucovorin, a synthetic form of vitamin B9, as a treatment for a rare genetic condition that causes folate deficiencies in the brain. The ...

Researchers from the University of Oxford have created the first high-resolution molecular atlas of the adult Drosophila ...

LEXINGTON, KY, UNITED STATES, March 11, 2026 / EINPresswire.com / — The Child Neurology Foundation (CNF) today announced Ambry Genetics, now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), ...

Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.

Her research group also receives funding from the Ministry of Science, Innovation and Universities, as well as the Regional Government of Galicia and FEDER. My grandmother Leontina, who recently ...

The FDA on Tuesday approved leucovorin as a treatment for a rare genetic syndrome, not for autism as the Trump administration had suggested ...

For the first time, scientists have used DNA preserved in ancient sediments to examine how a major natural disaster affected ...

The FDA is approving a generic drug for a very rare genetic disorder, but not for autism. On Tuesday, the U.S. agency said the drug helps children and adults who ...

The FDA has approved a generic drug for a very rare brain disorder, while walking back suggestions by Trump it showed promise for people with autism. (AP Photo) ...

In September, Trump and the FDA commissioner announced the drug was under review to benefit patients with autism. The FDA didn't find evidence of that.

The FDA has approved a generic drug for a very rare brain disorder, while walking back suggestions by Trump it showed promise for people with autism. (AP Photo) ...